Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens

Archives of Virology

Volumn 144, Issue 1, 1999, Pages 45-54

  Lee, S I ^a   Ohashi, K ^a   Morimura, T ^a   Sugimoto, C ^a   Onuma, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL SURFACE RECEPTOR; IMMUNIZATION; SEROTYPE; T LYMPHOCYTE; VIRULENCE; VIRUS ISOLATION;

ANIMALIA; AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPETOVIRUS; MARDIVIRUS;

EID: 0032951232     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050484     Document Type: Article

References (33)

1. 1. Becker Y, Asher Y, Tabor E, Davidson I, Malkinson M, Weisman Y (1992) Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3. J Virol Methods 40: 307-322
2. 2. Ben-Nathan D, Lusting S (1990) Production of Marek's disease virus. Adv Biotechnol Proc 14: 347-365
3. 3. Bradley G, Hayashi M, Lancz G, Tanaka A, Nonoyama M (1989) Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol 63: 2 534-2 542
4. 4. Buscaglia C, Calnek BW, Schat KA (1988) Effect of immunocompetence on the establishment and maintenance of latency of Marek's disease herpesvirus. J Gen Virol 69: 1067-1077
5. 5. Calnek BW (1992) Marek's disease: contribution to comparative herpes virology and oncology. Proc XIX World's Poultry Congress, Amsterdam, The Netherlands, 220-232
6. 6. Calnek BW (1986) Marek's disease - a model for herpesvirus oncology. CRC Crit Rev Microbiol 12:293-320
7. 7. Calnek BW, Lucio B, Schat KA, Lillehoj HS (1989) Pathogenesis of Marek's disease virus induced local lesions. 1. Lesion characterization and cell line establishment. Avian Dis 33: 291-302
8. 8. Calnek BW, Schat KA, Peckham MC, Fabricant J (1982) Research note - field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis 27: 844-849
9. 9. Chan MM, Chen CLH, Ager LL, Cooper MD (1988) Identification of the avian homologues of mammalian CD4 and CD8 antigens. J Immunol 140: 2 133-2 138
10. 10. Churchill AE, Payne LN, Chubb RC (1969) Immunization against Marek's disease using a live attenuated virus. Nature 221: 744-747
11. 11. Cui Z, Lee LF, Liu JL, Kung HJ (1991) Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38 and antigen associated with transformed cells. J Virol 65: 6 509-6 515
12. 12. Hiramoto Y, Lee SI, Morimura T, Ohashi K, Sugimoto C, Onuma M (1996) Reisolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens. In: Current research on Marek's disease. Rose Printing, Tallahassee, pp 130-135
13. + T cell depletion in chickens for the development of Marek's disease lymphoma and vaccine protection. In: Proceeding of XIX World's Poultry Congress, Amsterdam 1992. Phosen & Looijen, Wageningen, pp 246-250
14. 14. Luhtala M, Salmonsen J, Hirota Y, Onodera T, Toivanen P, Vainio O (1993) Analysis of chicken CD4 by monoclonal antibodies indicates evolutionary conservation between avian and mammalian species. Hybridoma 12: 633-646
15. 15. Morimura T. Hattori M, Ohashi K, Sugimoto C, Onuma M (1995) Immunomodulation of peripheral T cells in chickens infected with Marek's disease virus: involvement in immunosuppression. J Gen Virol 76: 2979-2985
16. 16. Morimura T, Ohashi K, Kon Y, Hattori M, Sugimoto C, Onuma M (1996) Apoptosis and CD8-down-regulation in the thymus of chickens infected with Marek's disease virus. Arch Virol 141: 2243-2249
17. 17. Morimura T, Ohashi K, Sugimoto C, Onuma M (1998) Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J Vet Med Sci 60: 1-8
18. 18. Okazaki W, Purchase HG, Burmester BR (1970) Protection against Marek's disease by vaccination with a herpesvirus of turkey. Avian Dis 14: 413-429
19. 19. Omar AR, Schat KA (1996) Syngenic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late and unique MDV proteins. Virology 222: 87-99
20. 20. Purchase HG, Okazaki W, Burmester BR (1971) Field trials with the herpesvirus of turkey (HVT) strain FC126 as a vaccine against Marek's disease. Poultry Sci 50: 775-783
21. 21. Rispens BH, van Vloten H, Mastenbroek N, Maas HJL, Schat KA (1972) Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (Strain CVI-988) and its use in laboratory vaccination trials. Avian Dis 16: 108-125
22. 22. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
23. 23. Schat KA (1987) Marek's disease: a model for protection against herpesvirus-induced tumors. Cancer Surv 6: 1-37
24. 24. Schat KA, Calnek BW (1978) Characterization of an apparently nononcogenic Marek's disease virus. J Natl Cancer Inst 60: 1 075-1 082
25. 25. Schat KA, Chen CLH, Calnek BW, Char D (1991) Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J Virol 65: 2 929-2 935
26. 26. Schat KA, Omar AR, Lee LF, Hunt H (1996) Induction of glycoprotein B (gB)-specific cytotoxic T cells after vaccination with recombinant fowlpox virus expressing gB. In: Current research on Marek's disease. Proceeding of 5th International Symposium on Marek's Disease. Rose Printing, Tallahassee, pp 432-435
27. 27. Shek WR, Calnek BW, Schat KA, Chen CLH (1983) Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J Natl Cancer Inst 70: 485-495
28. 28. Witter RL (1982) Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathol 11: 49-62
29. 29. Witter RL, Burmester BR (1979) Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. Avian Pathol 8: 145-156
30. 30. Witter RL, Lee LF (1984) Polyvalent Marek's disease vaccines: safety, efficacy, and protective synergism in chickens with maternal antibodies. Avian Pathol 13: 75-92
31. 31. Witter RL, Nazerian K, Purchase HG, Burgoyne HG (1970) Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res 31: 525-538
32. 32. Yoshida S, Lee LF, Yanagida N, Nazerian K (1994) The glycoprotein B genes of Marek's disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses. Virology 200: 484-493
33. 33. Zander DV, Hill RW, Raymond RG, Balch RK, Mitchell RW, Dunsing JW (1972) The use of blood from selected chickens as an immunizing agent for Marek's disease. Avian Dis 16: 163-178